Advantage Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$260K Buy
1,343
+17
+1% +$3.26K 0.2% 93
2019
Q2
$244K Sell
1,326
-23
-2% -$4.12K 0.19% 124
2019
Q1
$256K Sell
1,349
-13
-1% -$2.48K 0.2% 108
2018
Q4
$265K Buy
1,362
+45
+3% +$8.78K 0.2% 87
2018
Q3
$273K Buy
1,317
+359
+37% +$70.8K 0.18% 99
2018
Q2
$177K Sell
958
-379
-28% -$67K 0.13% 140
2018
Q1
$228K Sell
1,337
-305
-19% -$56K 0.09% 148
2017
Q4
$286K Sell
1,642
-158
-9% -$28K 0.09% 141
2017
Q3
$336K Buy
1,800
+18
+1% +$3.19K 0.11% 128
2017
Q2
$307K Sell
1,782
-4,488
-72% -$730K 0.11% 130
2017
Q1
$1.03M Buy
6,270
+255
+4% +$42.4K 0.41% 66
2016
Q4
$879K Buy
6,015
+694
+13% +$104K 0.33% 64
2016
Q3
$888K Buy
5,321
+235
+5% +$39.7K 0.32% 59
2016
Q2
$774K Sell
5,086
-9,848
-66% -$1.53M 0.36% 57
2016
Q1
$2.24M Buy
14,934
+441
+3% +$65.5K 0.96% 25
2015
Q4
$2.35M Buy
14,493
+739
+5% +$116K 1.22% 22
2015
Q3
$1.9M Buy
13,754
+12,358
+885% +$1.95M 1.09% 24
2015
Q2
$214K Sell
1,396
-374
-21% -$59.9K 0.1% 133
2015
Q1
$283K Buy
1,770
+635
+56% +$100K 0.16% 115
2014
Q4
$181K Buy
+1,135
New +$177K 0.14% 131

Other funds holding AMGN

Advantage Investment Management's AMGN Position: Q3 2019 in Review

Advantage Investment Management increased its Amgen (AMGN) stake by 1.3% in Q3 2019, buying an estimated $3.26K and bringing the position to 1,343 shares worth $260K. The position accounts for 0.2% of the portfolio, ranked #93.

Advantage Investment Management first reported a position in AMGN in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.35M in Q4 2015. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Advantage Investment Management held 1,343 shares of Amgen worth $260K as of Q3 2019.
  • Advantage Investment Management bought 17 Amgen shares in Q3 2019, an estimated $3.26K.
  • Amgen made up 0.2% of Advantage Investment Management's portfolio in Q3 2019, its #93 holding.
  • Advantage Investment Management first reported a position in Amgen in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Amgen position peaked at $2.35M in Q4 2015.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.